Abstract 4370764: Single Chamber (Right Atrial) Leadless Pacemaker to Prevent Ventricular Tachycardia

J John Weng (Mount Sinai Hospital, New York, New York, United States) A Ankita Naraparaju (Mount Sinai Hospital, New York, New York, United States) E Eileen Galvani (Mount Sinai Hospital, New York, New York, United States) M Marc Miller (Mount Sinai Hospital, New York, New York, United States)

Abstract

Introduction: Sudden changes in ventricular cycle lengths (or short-long-short [S-L-S] sequences) can initiate polymorphic ventricular tachycardia (VT). This pattern involves a premature ventricular beat (PVC), followed by a compensatory pause and subsequent premature beat. The compensatory pause leading to the long cycle is followed by a prolonged repolarization phase. Suppressing S-L-S sequences with anti-bradycardic pacing may prevent polymorphic VT in at-risk patients. Herein we describe a case of a patient being treated for fungal endocarditis who developed recurrent VT storm in whom anti-bradycardia pacing via a single-chamber right atrial pacemaker prevented further sustained VT episodes. Case: A 69-year-old patient with fungal bioprosthetic aortic valve endocarditis developed sustained VT, for which he was successfully resuscitated. He was prescribed a secondary prevention wearable defibrillator lifevest on discharge, but over a 2-week period the patient received 6 appropriate shocks by his wearable defibrillator for polymorphic and monomorphic VT episodes despite treatment with multiple anti-arrhythmic agents. In-patient telemetry identified S-L-S sequence preceding the VT episodes. Subsequently, a single chamber right atrial leadless pacemaker was placed and programmed to pace at eighty beats per minute. At 8 weeks post-implant, he experienced no further VT episodes (non-sustained or sustained). Discussion: Due to ongoing treatment for fungemia, placement of a transvenous pacing/defibrillator system was a relative contraindication, due to high risk for cardiac device infection. While a subcutaneous ICD could have been implanted with less infectious risk, it does not have pacing function, and would not have prevented further VT episodes. Conclusion: This case highlights a unique management strategy utilizing anti-bradycardia pacing via a single chamber right atrial leadless pacemaker to prevent ventricular arrhythmias triggered by S-L-S sequences when other treatment options were less plausible.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (4)

J

John Weng

Mount Sinai Hospital, New York, New York, United States

A

Ankita Naraparaju

Mount Sinai Hospital, New York, New York, United States

E

Eileen Galvani

Mount Sinai Hospital, New York, New York, United States

M

Marc Miller

Mount Sinai Hospital, New York, New York, United States